03:32 PM EST, 12/09/2024 (MT Newswires) -- Health care stocks rose late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.3%.

The iShares Biotechnology ETF (IBB) rose 0.5%.

In corporate news, GSK (GSK) shares climbed 4.6%. The company said a phase 3 trial showed a "statistically significant and clinically meaningful overall survival" for the belantamab mafodotin combination versus the daratumumab combination as a second line or later treatment for multiple myeloma.